The FDA approved a prefilled syringe format for Ani's purified Cortrophin Gel that should ease administration for MS patients ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

The FDA has approved Purified Cortrophin Gel (repository corticotropin injection USP) in a prefilled syringe presentation.

The prefilled syringe reduces administration steps for patients using Cortrophin Gel, which remains available in 5 mL and 1 mL vials. For full indications and important safety information, please see ...

ANI Pharmaceuticals, Inc. announced the FDA approval of its Purified Cortrophin® Gel in a prefilled syringe format, aimed at improving patient experience by reducing administration steps.

The prefilled syringe reduces administration steps for patients using Cortrophin Gel, which remains available in 5 mL and 1 mL vials. For full indications and important safety information ...

The differences between PFSs and MDVs (per 1000 doses) is 324.21. MDV: Multidose vial; NA: Not available; PFS: Prefilled syringe. Prefilled syringes (PFSs) have gained market share in the USA ...

Abbey said the approval of the Vabysmo prefilled syringe (faricimab, Genentech) for the treatment of retinal vein occlusion (RVO) added durability to some patients’ treatment. Faricimab is ...

The Global Prefilled Syringes Market was valued at $5.43 billion in 2022 and is projected to reach $10.59 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.70% during the forecast ...